1.76
price up icon1.15%   0.02
after-market After Hours: 1.77 0.01 +0.57%
loading
Mereo Biopharma Group Plc Adr stock is traded at $1.76, with a volume of 1.36M. It is up +1.15% in the last 24 hours and down -36.92% over the past month. Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
See More
Previous Close:
$1.74
Open:
$1.75
24h Volume:
1.36M
Relative Volume:
0.64
Market Cap:
$279.84M
Revenue:
$10.00M
Net Income/Loss:
$-29.47M
P/E Ratio:
-8.80
EPS:
-0.2
Net Cash Flow:
$-21.55M
1W Performance:
-0.56%
1M Performance:
-36.92%
6M Performance:
-39.52%
1Y Performance:
-56.86%
1-Day Range:
Value
$1.71
$1.80
1-Week Range:
Value
$1.65
$1.885
52-Week Range:
Value
$1.57
$5.02

Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile

Name
Name
Mereo Biopharma Group Plc Adr
Name
Phone
4403330237300
Name
Address
ONE CAVENDISH PLACE, LONDON
Name
Employee
36
Name
Twitter
@MereoBioPharma
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
MREO's Discussions on Twitter

Compare MREO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MREO
Mereo Biopharma Group Plc Adr
1.76 276.66M 10.00M -29.47M -21.55M -0.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-27-25 Initiated JP Morgan Overweight
Dec-06-24 Initiated Jefferies Buy
Jun-13-24 Initiated Robert W. Baird Outperform
Oct-13-23 Resumed BTIG Research Buy
Aug-12-22 Initiated Cantor Fitzgerald Overweight
May-05-21 Initiated BTIG Research Buy
Apr-05-21 Initiated Needham Buy
View All

Mereo Biopharma Group Plc Adr Stock (MREO) Latest News

pulisher
Jul 23, 2025

Investors in Mereo BioPharma Group plc (MREO) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - GlobeNewswire Inc.

Jul 23, 2025
pulisher
Jul 22, 2025

MREO ACTIVE INVESTIGATION: Lost Money on Mereo BioPharma Group plc? Contact Levi & Korsinsky Now - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

Mereo BioPharma Group plc (MREO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plcMREO - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

ATTENTION MREO Shareholders: Lost Money on Mereo BioPharma Group plc? Contact Levi & Korsinsky About Investigation - ACCESS Newswire

Jul 22, 2025
pulisher
Jul 21, 2025

Mereo BioPharma Group plc (MREO) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

Investigation Opened on Behalf of Mereo BioPharma Group plc (MREO) ShareholdersContact Levi & Korsinsky - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 20, 2025

Ongoing Securities Investigation into Mereo BioPharma Group plc (MREO)Contact Levi & Korsinsky - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Mereo BioPharma Group plc (MREO) And Encourages Stockholders to Connect - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 19, 2025

Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Given Consensus Rating of “Buy” by Brokerages - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Investigation Underway: Mereo BioPharma Group plc (MREO)Contact Levi & Korsinsky Over Securities Law Violations - ACCESS Newswire

Jul 19, 2025
pulisher
Jul 18, 2025

Mereo BioPharma Group plc (MREO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 18, 2025

MREO ALERT: Ongoing Investigation Into Mereo BioPharma Group plcContact Levi & Korsinsky - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 17, 2025

Protect Your Investment: Contact Levi & Korsinsky About the Mereo BioPharma Group plc (MREO) Investigation - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 17, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mereo BioPharma Group plc (MREO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 11, 2025

BTIG reiterates Buy rating on Mereo BioPharma stock amid trial progress By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 10, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.43% - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

United States shares higher at close of trade; Dow Jones Industrial Average up 0.43% - Investing.com India

Jul 10, 2025
pulisher
Jul 10, 2025

RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End - Yahoo Finance

Jul 10, 2025
pulisher
Jul 10, 2025

JPMorgan maintains Mereo BioPharma stock rating despite trial setback By Investing.com - Investing.com India

Jul 10, 2025
pulisher
Jul 10, 2025

JPMorgan maintains Mereo BioPharma stock rating despite trial setback - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

Mereo BioPharma and Ultragenyx advance Phase 3 Orbit study for osteogenesis imperfecta - Investing.com India

Jul 10, 2025
pulisher
Jun 09, 2025

SEC Form N-CSRS filed by abrdn World Healthcare Fund Shares of Beneficial Interest - Quantisnow

Jun 09, 2025
pulisher
May 22, 2025

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), ACADIA Pharmaceuticals (ACAD) and Quanterix (QTRX) - The Globe and Mail

May 22, 2025
pulisher
May 21, 2025

Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

May 21, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Organon (OGN), Diamedica Therapeutics (DMAC) and Nkarta (NKTX) - The Globe and Mail

May 16, 2025
pulisher
May 13, 2025

Mereo BioPharma Group plc SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights - GlobeNewswire

May 13, 2025
pulisher
May 01, 2025

Mereo Biopharma Group Plc ADR (MREO) can make a big difference with a little luck - Sete News

May 01, 2025
pulisher
Apr 29, 2025

Analyzing Mereo Biopharma Group Plc ADR (MREO) After Recent Trading Activity - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

How should investors view Mereo Biopharma Group Plc ADR (MREO)? - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Analytical Overview: Mereo Biopharma Group Plc ADR (MREO)’s Ratios Tell a Financial Story - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Balance Sheet Insights: Halliburton Co (HAL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

INN’s latest rating updates from top analysts. - knoxdaily.com

Apr 29, 2025
pulisher
Apr 25, 2025

EVLV’s 2023 Market Dance: Down -10.63% – Time to Invest? - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Mereo Biopharma Group Plc ADR: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Mereo Biopharma Group Plc ADR [MREO] Shares Fall -0.78 % on Thursday - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Brookdale Senior Living Inc [BKD] Records 50-Day SMA of $5.84 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

VST Stock Sees Surge of Approximately 7.21% in Last Five Days - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Core & Main Inc [NYSE: CNM] Sees Increase in Stock Value - knoxdaily.com

Apr 25, 2025
pulisher
Apr 23, 2025

This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO) - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

Financial Metrics Check: B. Riley Financial Inc (RILY)’s Ratios for Trailing Twelve Months - DWinneX

Apr 23, 2025
pulisher
Apr 22, 2025

Mereo Biopharma Group Plc ADR [MREO] Investment Appeal on the Rise - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Freeport-McMoRan Inc [FCX] Stock sold by Insider Robertson Maree E. for $0.58 million - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

D.R. Horton Inc (DHI) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Insider Sale Alert: Genworth Financial Inc [GNW] – Is it Time to sell? - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Mereo Biopharma Group Plc ADR (MREO) requires closer examination - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

SMX (Security Matters) Plc (SMX) shows promising results - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Should investors be concerned about Uranium Energy Corp (UEC)? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Is Aquestive Therapeutics Inc (AQST) worth investing in despite its overvalued state? - uspostnews.com

Apr 22, 2025

Mereo Biopharma Group Plc Adr Stock (MREO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):